Midazolam-ketamine combination for moderate sedation in upper GI endoscopy

Farzaneh Motamed1, Yasaman Aminpour, Hesam Hashemian

  • 1Department of Gastroenterology, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Oral ketamine with IV midazolam provided safe and effective sedation for pediatric upper gastrointestinal endoscopy (UGIE). This combination led to better patient comfort and faster recovery compared to other regimens.

Area of Science:

  • Pediatric Gastroenterology
  • Anesthesiology
  • Sedation Pharmacology

Background:

  • Effective sedation is crucial for pediatric upper gastrointestinal endoscopy (UGIE) to ensure patient comfort and procedural success.
  • Optimizing sedation regimens in children requires balancing efficacy, safety, and patient experience.

Purpose of the Study:

  • To compare the quality of sedation using three distinct regimens in pediatric patients undergoing UGIE.
  • To evaluate the efficacy and safety of oral ketamine and intravenous midazolam compared to placebo and oral fentanyl.

Main Methods:

  • A randomized study involving 150 pediatric patients undergoing UGIE.
  • Three groups received different sedation: Group A (placebo + IV midazolam), Group B (oral ketamine + IV midazolam), and Group C (oral fentanyl + IV midazolam).
  • Sedation depth and patient comfort were primary endpoints, with safety and recovery time also assessed.

Main Results:

  • Group B (oral ketamine + IV midazolam) demonstrated significantly lower midazolam requirements.
  • Patients in Group B experienced less distress during IV placement and parental separation, higher comfort, and greater endoscopist satisfaction.
  • Group B showed a shorter recovery time, with all regimens proving safe and complications managed successfully.

Conclusions:

  • Synergistic sedation with oral ketamine and IV midazolam is a safe and suitable option for pediatric UGIE.
  • The oral route of ketamine administration may contribute to a higher incidence of vomiting compared to previous studies.
  • This regimen offers advantages in terms of patient comfort, procedural ease, and recovery efficiency.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...